AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS conference gets underway in Vegas.

Texas Gov. Greg Abbott has released a 155-page report outlining his plan for the future of business, innovation, ...

It only takes a quick scan of any cable news network to realize that we have entered a whole new age of uncertainty. For many ...

Corporation outlined how ongoing investments will aim to accelerate its strategy and drive billions of dollars of profitable sales ...

B2B tech startups often face the challenge of establishing themselves as category leaders while navigating long sales cycles, ...

Stronger social security and unemployment benefits are among the key support measures they would like to see, some Chinese ...

Chart Industries' 29.4% order intake growth signals strong performance and earnings visibility. See here to know why we ...

Comfort Systems USA has a wide economic moat built upon their scale, industry knowledge, and tangible switching costs for ...

Roku makes technology that allows your TV set to play on-demand streaming content. It competes with Alphabet 's Google ...

Nvidia just published its latest earnings report beating Wall Street forecasts, but is NVDA stock still a buy?

The Home Depot Inc. HD has reported fourth-quarter fiscal 2024 results, wherein earnings and sales surpassed the Zacks ...

A few weeks after considering buyout offers, federal workers faced another dilemma: Responding to Elon Musk's "What did you ...